Redx Immunology Limited

#09000503 Active

Redx Pharma Plc is a clinical-stage biotechnology company dedicated to discovering and developing novel, small molecule medicines targeting fibrotic diseases and cancer. Their innovative approach focuses on creating best-in-class treatments for unmet medical needs.

Founded: 16 Apr 2014
Industries:
72110 - Research and experimental development on biotechnology
Location: Macclesfield

Products & Services

• biotechnology
• cancer treatment
• clinical development
• drug discovery
• fibrotic diseases
• pharmaceutical company
• rxc008 (gi-targeted pan-rock inhibitor)
• small molecule drugs
• zamaporvint (rxc004, porcupine inhibitor)
• zelasudil (rxc007)

Financial Snapshot

Last accounts made up to 30 Sept 2024
Next accounts due 30 Jun 2026 (7 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
2
Shareholders
1
Controllers (PSC)
2
Lisa Mary Whewell Anson
Director • British • Lives in England • Born in Apr 1968
Peter Collum
Director • American • Lives in United States • Born in Jun 1972

Registered Office Address

Block 33 Mereside

Alderley Park

Macclesfield

SK10 4TG

England

Basic Information

LTD
16 Apr 2014
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

11
Officers
2
PSCs
0
Filings